Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene

Cancer Research

Volumn 57, Issue 1, 1997, Pages 1-6

  Wiest, Jonathan S ^a,e   Franklin, Wilbur A ^b   Otstot, John T ^a   Forbey, Kristian ^a   Varella Garcia, Marileila ^b   Rao, Kalpana ^b   Drabkin, Harry ^b   Gemmill, Robert ^b   Ahrent, Steve ^c   Sidransky, David ^c   Saccomanno, Geno ^a   Fountain, Jane W ^d   Anderson, Marshall W ^a  

^a St Mary's Hospital Grand Junction   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 9P; CHROMOSOME DELETION; ENZYME INHIBITION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ISOLATION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 0031023126     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Minna, J. D., Pass, H., Glatstein, E., and Inde, D. C. Lung cancer. In: V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 591-687. Philadelphia: Lippincott, 1989.
2. Bechtel, J. J., Kelley, W. R., Patz, D. S., Petty, T. L., and Saccomanno, G. Outcome of 54 patients with roentgenographic occult lung cancer detected by sputum cytology. Arch. Intern. Med., 154: 975-980, 1994.
3. Rodenhuis, S., and Slebos, R. J. C. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52 (Suppl.): 2665s-2669s, 1992.
4. Schauer, I., Siriwardana, S., Langan, T. A., and Sclafani, R. A. Cyclin D1 overexpression vs. Rb inactivation. implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 7827-7831, 1994.
5. Gazzeri, S., Brambilla, E., Jacrot, M., Chauvin, C., Benabid, A. L., and Brambilla, C. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res., 51: 2566-2571, 1991.
6. Merlo, A., Gabrielson, E., Askin, F., and Sidransky, D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54: 640-642, 1994.
7. Merlo, A., Gabrielson, E., Mabry, M., Vollmer, R., Baylin, S. B., and Sidransky, D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res., 54: 2322-2326, 1994.
8. van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
9. Stadler, W. M., Sherman, J., Bohlander, S. K., Roulston, D., Dreyling, M., Rukstalis, D., and Olopade, O. I. homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res., 54: 2060-2063, 1994.
10. Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J. M., Vlock, D. R, Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., Lahti, J., Kidd, V. J., Housman, D. E., and Dracopoli, N. C. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. Natl. Acad. Sci. USA, 89: 10557-10561, 1992.
11. Cheng, J. Q., Jhanwar, S. C., Klein, W. M., Bell, D., Lee, W., Altomar, D. A., Nobori, T., Olopade, O. I., Buckler, A. J., and Testa, J. R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelimoa. Cancer Res., 54: 5547-5551, 1994.
12. Olopade, O. I., Jenkins, R. B., Ransom, D. T., Malik, K., Pomykala, H., Nobori, T., Cowan, J. M., Rowley, J. D., and Diaz, M. O. molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 52: 2523-2529, 1992.
13. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
14. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994.
15. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
16. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat. Genet., 11: 210-212, 1995.
17. Vos, S., Miller, C., Takeuchi, S., Gombart, A., Cho, S., and Koeffler, H. Alteration of CDKN2 (p16) in non-small cell lung cancer. Genes Chromosomes & Cancer., 14: 164-170, 1995.
18. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55: 1448-1451, 1995.
19. Puig, S., Ruiz, A., Lazaro, C., Castel, T., Lynch, M., Palou, J., Vilalta, A., Weissenbach, J., Mascaro, J., and Estivill, X. Chromosome 9p deletions in cutaneous malignant melanoma tumors. The minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet., 57: 395-402, 1995.
20. Olopade, O. I., Pomykala, H. M., Hagos. F., Sveen, L. W., Espinosa, R., III, Dreyling, M. H., Gursky, S., Stadler, W. M., LeBeau, M. M., and Bohlander, S. K. Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc. Natl. Acad. Sci. USA, 92: 6489-6493, 1995.
21. Coleman, A., Fountain, J. W., Nobori, T., Olopade, O. I., Robertson, G., Housman, D. E., and Lugo, T. G. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res., 54: 344-348, 1994.
22. Ichimura, K., Schmidt, E. E., Yamaguchi, N., James, C. D., and Collins, V. P. A common region of homozygous deletion in malignant human gliomas lies between the IFN α/ω gene cluster and the D9S171 locus. Cancer Res. 54: 3127-3130, 1994.
23. Holland, E. A., Beaton, S. C., Edwards, B. G., Kefford, R. F., and Mann, G. J. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene, 9: 1361-1365, 1994.
24. Schmidt, E. E., Ichimura, K., Reifenberger, G., and Collins, V. P. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54: 6321-6324, 1994.
25. Tannin, L., Yin, J., Zhou, X., Suzuki, H., Jiang, H-Y., Rhyu, M-G., Abraham, J. M., Krasna, M. J., Cottrell, J., and Meltzer, S. J. Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res., 54: 6094-6096, 1994.
26. Neville, E. M., Stewart, M., Myskow, M., Donnelly, R. J., and Field, J. K. Loss of heterozgosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene, 11: 581-585, 1995.
27. Lydiatt, W., Murty, V. V. V. S., Davidson, B., Xu, L., Dyomina, K., Sacks, P., Schantz, S., and Chaganti, R. S. K. Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors. Genes Chromosomes & Cancer, 13: 94-98, 1995.
28. Whetsell, L., Maw, G., Nadon, N., Ringer, D., and Schaefer, F. Polymerase chain reaction microanalysis of tumors from stained histological slides. Oncogene, 7: 2355-2361, 1992.
29. Mellersh, C., and Sampson, J. Simplifying detection of microsatellite length polymorphisms. BioTechniques, 15: 582-584, 1993.
30. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422-1424, 1994.
31. Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem., 31: 1333-1335, 1983.
32. Fountain, J. W., Karayiorgou, M., Taruscio, D., Graw, S. L., Buckler, A. J., Ward, D. C., Dracopoli, N. C., and Housman, D. E. Genetic and physical map of the interferon region on chromosome 9p. Genomics, 14: 105-112, 1992.
33. Bohlander, S. K., Espinosa, R., III, Fernald, A. A., Rowley, J. D., Le Beau, M. M., and Diaz, M. Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescent in situ hybridization. Cytogenet. Cell Genet., 65: 108-110, 1994.
34. Roche, J., Boldog, F., Robinson, M., Robinson, L., Varella-Garcia, M., Swanton, M., Waggoner, B., Fishel, R., Franklin, W., Gemmill, R., and Drabkin, H. Distinct 3p21.3 deletions in lung cancer and identification of a new semaphorin. Oncogene, 12: 1289-1297, 1996.
35. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrent, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56: 3630-3633, 1996.
36. Hayashi, N., Sugimoto, Y., Tsuchiya, E., Ogwaw, M., and Nakamura, Y. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4I (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small lung carcinoma. Biochem. Biophys. Res. Commun., 202: 1426-1430, 1994.
37. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.